Wilhelmus Cm Groenhuysen, Chief Operating Officer at NovoCure Ltd (NVCR), sold 16,124 shares at $109.23 ($1.8M) on 2020-09-18, disclosed to the SEC on 2020-09-21.
Open-market sale of $1.8M NVCR by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $106.92 | 200 | $21K | 1.2% |
| 2 | $108.49 | 2,513 | $273K | 15.5% |
| 3 | $108.49 | 2,513 | $273K | 15.5% |
| 4 | $109.23 | 3,536 | $386K | 21.9% |
| 5 | $109.23 | 3,536 | $386K | 21.9% |
| 6 | $110.24 | 1,813 |
| $200K |
| 11.3% |
| 7 | $110.24 | 1,813 | $200K | 11.3% |
| 8 | $110.89 | 200 | $22K | 1.3% |
| Total | $109.22 avg | 16,124 | $1.8M | 100% |
| Filing → |
| NVCR | SELL | 2023-09-05 | $6K | — | Filing → |
| NVCR | SELL | 2023-03-07 | $3.9M | — | Filing → |
| NVCR | SELL | 2023-03-06 | $183K | — | Filing → |